TrialAnnals of the rheumatic diseases2021

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.

Bernard Combe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.